Quantcast vic
Ennis & Ennis, P.A. | Personal Injury Attorney
1.800.856.6405

Follow Us

 

Pradaxa Side Effects
______________________________________________________________________

Pradaxa Side Effects Lawsuit News - Pradaxa Lawyer
______________________________________________________________________



Bookmark and Share

Pradaxa Bleeds – Do You Have a Pradaxa Lawsuit?

Ennis & Ennis, P.A. Outlines the Criteria for Potential Pradaxa Bleed Lawsuits

- Ennis & Ennis News

11/28/2012 - Boehringer Ingelheim Pharmaceutical’s anticoagulant drug, Pradaxa, does not carry an increased risk of fatal bleeds when compared with other anticoagulants such as Coumadin, however the increased fatal risk presents itself once a Pradaxa patient suffers a bleed because there is currently no reversal agent to stop the bleed.  With other anticoagulants on the market that offer antidotes to stop bleeds, it is alarming that Pradaxa continues to remain on the market.

On October 19, 2010, the FDA approved Pradaxa for patients with atrial fibrillation to reduce the risk for stroke and blood clots.  By October 6, 2011, the Institute for Safe Medication Practices, (ISMP), reported that Pradaxa had the highest adverse event rankings, with more reports than 98.7% of the drugs it regularly monitors.  In 2011 alone, there were over 3,781 adverse events reports filed with the U.S. Food and Drug Administration (FDA) including 2,367 hemorrhages, 644 strokes and 542 deaths, which finally prompted FDA involvement.  On December 7, 2011, the FDA issued a Safety Communication that it was investigating reports of serious and fatal bleeds in Pradaxa patients.  

However, prior to October 2011, the Pradaxa bleed dangers presented globally.  In fact, Pradaxa became available in Japan in January 2011 and within months Japanese regulators issued a safety advisory after receiving 81 reports of serious side effects, including five deaths.  Japanese regulators even asked Pradaxa drug makers to warn doctors of the dangerous risks associated with Pradaxa, but the request fell upon deaf ears.  

Who May Qualify for Compensation?

Patients who have suffered a significant bleed, such as a gastrointestinal bleed or an intra or intercerebral hemorrhage, or a stroke caused by a bleed may be entitled to compensation.

How to Hire an Pradaxa Lawyer

Hiring an attorney is not a difficult or expensive experience. Attorneys handling personal injury litigation, as described above, work on a contingency fee agreement. This means the attorney receives a percentage of the recovery received in the litigation. If there is no recovery by the client, there are no fees or costs charged to the client. Consultations to determine whether a client has a case are also free.  So nothing ever comes out of the client’s pocket.

Pradaxa Side Effects Lawsuit Information::

Pradaxa Side Effects Lawyer Accepting Cases

If you or a loved one have suffered serious side effects of Pradaxa, Pradaxa injury or death while using Pradaxa you may be entitled to compensation. Contact the Pradaxa side effects lawyers of Ennis & Ennis, P.A. today for a free nationwide case evaluation. Our experienced Pradaxa attorneys can answer any questions you may have about Pradaxa litigation, Pradaxa side effects, a potential Pradaxa lawsuit or even a possible Pradaxa class action lawsuit. Fill out the Pradaxa lawsuit case evaluation form on this page or call toll free: 1.800.856.6405.

Offices:
Washington DC Office
1101 Pennsylvania Ave.
Suite 600
Washington, DC 20004
Telephone: 202.756.2972
Miami Office
1111 Brickell Avenue
11th Floor
Miami, FL 33131
Telephone: 305.913.7199
Fort Lauderdale Office
110 E. Broward Blvd.
Suite 1700
Fort Lauderdale, FL 33301
Telephone: 954.315.3934
Facsimile: 954.315.3914


Required fields in Red:
 
Name:
Email:
 
Telephone:
(123-123-1234)
 
Mailing Address:
 
City:
 
State:
 
Zip Code:
Please List The Drug, Medical Device or Defective Product You Are Inquiring About:
Please List Any Side Effects, Injuries, or Property Damage:
Additional Information:
 
 
1.800.856.6405
©2010 Ennis & Ennis, P.A. All rights reserved.